Surgical necrotizing enterocolitis

Although currently available data are variable, it appears that the incidence of surgical necrotizing enterocolitis (NEC) has not decreased significantly over the past decade. Pneumoperitoneum and clinical deterioration despite maximal medical therapy remain the most common indications for operative treatment. Robust studies linking outcomes with specific indications for operation are lacking. Promising biomarkers for severe NEC include fecal calprotectin and S100A12; serum fatty acid-binding protein; and urine biomarkers.

Source: Seminars in Perinatology - November 7, 2016 Category: Perinatology & Neonatology Authors: Jamie R. Robinson, Eric J. Rellinger, L. Dupree Hatch, Joern-Hendrik Weitkamp, K. Elizabeth Speck, Melissa Danko, Martin L. Blakely Source Type: research